Translational Science Pilot Award supports Columbia faculty testing solutions to shared research barriers, funding projects that help translate discoveries into better health across diseases and conditions.
Funder: Columbia University Irving Medical Center
Due Dates: November 24, 2026 (Application deadline)
Funding Amounts: $50,000 for June 1, 2027–May 31, 2028
Summary: Supports innovative projects that overcome shared research barriers and produce broadly applicable translational science solutions.
Key Information: Principal investigators must hold a Columbia University faculty appointment at assistant professor rank or higher.
The Translational Science Pilot Award is offered by the Irving Institute for Clinical and Translational Research’s Pilot Program at Columbia University Irving Medical Center. It supports projects addressing common scientific and operational barriers that slow the translation of discoveries into improved human health. Projects may span basic science, clinical implementation, and community and public health delivery and scale-up.
Proposals should identify an innovation or barrier, test an approach to addressing it, and evaluate the approach’s effectiveness. A central goal is producing solutions applicable across diseases and conditions, with deliverables such as playbooks, toolkits, methods, or software that extend their use beyond the project. Disease-specific projects are welcome when they address a broader translational science need and generate knowledge, methods, or tools relevant beyond one disease area.